Clinical Microbiology Newsletter
Volume 30, Issue 10 , Pages 71-77 , 15 May 2008

Newer β-Lactamases: Clinical and Laboratory Implications, Part I*

  • Ellen Smith Moland, B.S.M.T

      Affiliations

    • Corresponding Author InformationMailing Address: Ellen Smith Moland, B.S.M.T., Center for Research in Antiinfectives and Biotechnology, Department of Medical Microbiology and Immunology, Creighton University School of Medicine, Omaha, Nebraska 68178. Tel.: 402-280-2921. Fax: 402-280-1875.
    • ,
  • Soo-Young Kim, M.D.
    • ,
  • Seong Geun Hong, M.D.
    • ,
  • Kenneth S. Thomson, Ph.D.

References 

  1. Livermore DM , et al.   Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests . J. Antimicrob. Chemother. . 2002;49:289–300
  2. Tenover FC , et al.   Detection and reporting of organisms producing extended-spectrum ß-lactamases: survey of laboratories in Connecticut . J. Clin. Microbiol. . 1999;37:4065–4070
  3. Paterson DL , Bonomo RA . Extended-spectrum beta-lactamases: a clinical update . Clin. Microbiol. Rev. . 2005;18:657–686
  4. Pangon B , et al.   In vivo selection of a cephamycin resistant porin mutant of a CTX-1 ß-lactamase producing strain of Klebsiella pneumoniae . J. Infect. Dis. . 1989;159:1005–1006
  5. Martinez-Martinez L , et al.   In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins . Antimicrob. Agents Chemother. . 1996;40:342–348
  6. Ardanuy C , et al.   Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems . Antimicrob. Agents Chemother . 1998;42:1636–1640
  7. Hernandez-Alles S , et al.   Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes . Antimicrob. Agents Chemother. . 1999;43:937–939
  8. Crowley B , Benedi VJ , Domenech-Sanchez A . Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems . Antimicrob. Agents Chemother. . 2002;46:3679–3682
  9. Nelson EC , Segal H , Elisha BG . Outer membrane protein alterations and blaTEM-1 variants: their role in {beta}-lactam resistance in Klebsiella pneumoniae . J. Antimicrob. Chemother. . 2003;52:899–903
  10. Skopkova-Zarnayova M , et al.   Outer membrane protein profiles of clonally related Klebsiella pneumoniae isolates that differ in cefoxitin resistance . FEMS Microbiol. Lett. . 2005;243:197–203
  11. Lee CH , et al.   In vivo selection of OmpK35-deficient mutant after cefuroxime therapy for primary liver abscess caused by Klebsiella pneumoniae . J. Antimicrob. Chemother. . 2006;58:857–860
  12. Burgess DS , et al.   Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period . Pharmacotherapy . 2003;23:1232–1237
  13. Paterson DL , et al.   Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: implications for antibiotic choice for spontaneous bacterial peritonitis . Clin. Infect. Dis. . 1999;28:683–684
  14. Pillay T , et al.   Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates . Am. J. Perinatol. . 1998;15:47–51
  15. Karadenizli A , et al.   Piperacillin with and without tazobactam against extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa in a rat thigh abscess model . Chemotherapy . 2001;47:292–296
  16. Bush K , Jacoby GA , Medeiros AA . A functional classification scheme for ß-lactamases and its correlation with molecular structure . Antimicrob. Agents Chemother. . 1995;39:1211–1233
  17. Thomson KS , Smith Moland E . Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium . Microbes Infect. . 2000;2:1225–1235
  18. al Naiemi N , Duim B , Bart A . A CTX-M extended-spectrum beta-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia . J. Med. Microbiol. . 2006;55:1607–1608
  19. Lewis JS , et al.   First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system . Antimicrob. Agents Chemother. . 2007;51:4015–4021
  20. Moubareck C , et al.   Countrywide spread of community- and hospital-acquired extended-spectrum beta-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon . J. Clin. Microbiol. . 2005;43:3309–3313
  21. Moland ES , et al.   Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from five U.S. States . Antimicrob. Agents Chemother. . 2003;47:2382–2383
  22. Power P , et al.   Biochemical characterization of PER-2 and genetic environment of blaPER-2 . Antimicrob. Agents Chemother. . 2007;51:2359–2365
  23. Brun-Buisson C , et al.   Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae . Lancet . 1987;ii:302–306
  24. Jarlier V , et al.   Extended broad-spectrum ß-lactamases conferring transferable resistance to newer ß-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns . Rev. Infect. Dis. . 1988;10:867–878
  25. Espedido BA , Thomas LC , Iredell JR . Metallo-beta-lactamase or extended-spectrum beta-lactamase: a wolf in sheep's clothing . J. Clin. Microbiol. . 2007;45:2034–2036
  26. Thomson KS , et al.   Comparison of Phoenix and VITEK 2 extended-spectrum-beta-lactamase detection tests for analysis of Escherichia coli and Klebsiella isolates with well-characterized beta-lactamases . J. Clin. Microbiol. . 2007;45:2380–2384
  27. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
  28. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; 15th informational supplement M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
  29. Poirel L , et al.   Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital . J. Clin. Microbiol. . 2003;41:3542–3547
  30. Sanders WE , Sanders CC . Enterobacter spp.: pathogens poised to flourish at the turn of the century . Clin. Microbiol. Rev. . 1997;10:220–241

 Editor's Note: Part II of this article will be published in the June 1, 2008 issue of CMN (Vol. 30, No. 11).

PII: S0196-4399(08)00022-6

doi: 10.1016/j.clinmicnews.2008.04.004

Clinical Microbiology Newsletter
Volume 30, Issue 10 , Pages 71-77 , 15 May 2008

Article Tools

* Image Usage & Resolution